Release Date: 28/04/16 19:11 Summary: 2015 Annual Report to Shareholders-SWE.AX Price Sensitive: No Download Document 3.28MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%